Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check28 days agoChange DetectedThe funding/operating-status notice banner was removed. The study details, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedNo additions or deletions were detected on the page. The content appears unchanged between the two screenshots.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference5%

- Check78 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; no other substantive changes to content, pricing, stock, or time slots.SummaryDifference0.3%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.